Recombinant
RabMAb

Anti-MMP9 antibody [EP1255Y] - Low endotoxin, Azide free (ab219372)

Publishing research using ab219372? Please let us know so that we can cite the reference in this datasheet.

ab219372 has been referenced in 8 publications.

  • Duan Y  et al. Targeted silencing of CXCR4 inhibits epithelial-mesenchymal transition in oral squamous cell carcinoma. Oncol Lett 12:2055-2061 (2016). WB . PubMed: 27602138
  • Xiao H  et al. TAZ regulates cell proliferation and epithelial-mesenchymal transition of human hepatocellular carcinoma. Cancer Sci 106:151-9 (2015). Human . PubMed: 25495189
  • Cicchini C  et al. Epigenetic control of EMT/MET dynamics: HNF4a impacts DNMT3s through miRs-29. Biochim Biophys Acta 1849:919-29 (2015). ICC/IF . PubMed: 26003733
  • Wei X  et al. Proteomics-based identification of the tumor suppressor role of aminoacylase 1 in hepatocellular carcinoma. Cancer Lett 351:117-25 (2014). WB ; Human . PubMed: 24846301
  • Tang L  et al. Inhibition of invasion and metastasis by DMBT, a novel trehalose derivative, through Akt/GSK-3ß/ß-catenin pathway in B16BL6 cells. Chem Biol Interact 222C:7-17 (2014). PubMed: 25148938
  • Brocqueville G  et al. LMP1-induced cell death may contribute to the emergency of its oncogenic property. PLoS One 8:e60743 (2013). WB . PubMed: 23637765
  • Zamilpa R  et al. Transgenic overexpression of matrix metalloproteinase-9 in macrophages attenuates the inflammatory response and improves left ventricular function post-myocardial infarction. J Mol Cell Cardiol 53:599-608 (2012). WB . PubMed: 22884843
  • Steude JS  et al. Mammographic Density and Matrix Metalloproteinases in Breast Tissue. Cancer Microenviron : (2009). IHC-P ; Human . PubMed: 20012240

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up